Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert J. Alpern currently holds 10,409 shares of AbbVie Inc. (ABBV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Alpern has been a net seller of ABBV stock. They have purchased $0 and sold $1.6M worth of shares.
Robert J. Alpern's most recent insider trade was on Dec 31, 2025, when they sold 62 shares at $125.29 per share.
Robert J. Alpern serves as Executive at AbbVie Inc. (ABBV). They have executed 61 insider transactions totaling $1.6M over their tenure at the company.
Robert J. Alpern holds the position of Executive at AbbVie Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Robert J. Alpern has shown a selling trading pattern, with $0 in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert J. Alpern was on Mar 28, 2019, when they sold $470.8K worth of TCDA shares. This transaction involved 14,000 shares at $33.63 per share.
Robert J. Alpern currently owns 10,409 shares of AbbVie Inc. (ABBV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert J. Alpern's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert J. Alpern has 61 Form 4 filings on record as an insider at AbbVie Inc..
Set alerts for Robert J. Alpern and 40,000+ other insiders.